These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 15755960)

  • 21. Endocrine therapy for breast cancer prevention in high-risk women: clinical and economic considerations.
    Groom AG; Younis T
    Expert Rev Pharmacoecon Outcomes Res; 2016; 16(2):245-55. PubMed ID: 26923683
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Sequential therapy with tamoxifen and aromatase inhibitors in early-stage postmenopausal breast cancer: a review of the evidence.
    Litsas G
    Oncol Nurs Forum; 2008 Jul; 35(4):714-21. PubMed ID: 18591176
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identifying breast cancer patients most likely to benefit from aromatase inhibitor therapy after adjuvant tamoxifen.
    Booth CM; Pater JL; Goss PE
    Cancer; 2007 May; 109(9):1927-8; author reply 1928. PubMed ID: 17354227
    [No Abstract]   [Full Text] [Related]  

  • 24. [Neoadjuvant antihormonal treatment of women with breast cancer].
    Tuxen MK; Kamby C; Nielsen DL
    Ugeskr Laeger; 2007 Sep; 169(37):3077-81. PubMed ID: 17877952
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Understanding the BIG results: Insights from the BIG 1-98 trial analyses.
    Wardley AM
    Adv Ther; 2008 Dec; 25(12):1257-75. PubMed ID: 19096768
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Adjuvant treatment of breast cancer. Endocrine therapy].
    Mouridsen HT; Andersen J
    Ugeskr Laeger; 2007 Sep; 169(37):3072-6. PubMed ID: 17877951
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Future endocrine therapy of breast cancer].
    Ejlertsen B
    Ugeskr Laeger; 2007 Jan; 169(4):296. PubMed ID: 17274921
    [No Abstract]   [Full Text] [Related]  

  • 28. Aromatase inhibitor and bone.
    Miki Y; Suzuki T; Sasano H
    Biomed Pharmacother; 2007 Oct; 61(9):540-2. PubMed ID: 17904790
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Recent research highlights importance of trials halted 10 years ago.
    Whitworth A
    J Natl Cancer Inst; 2006 Jan; 98(2):90-1. PubMed ID: 16418510
    [No Abstract]   [Full Text] [Related]  

  • 30. Optimising adjuvant endocrine treatment of breast cancer with aromatase inhibitors.
    Fentiman IS
    Int J Clin Pract; 2006 Jun; 60(6):689-93. PubMed ID: 16805754
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Aromatase inhibitors and cardiac toxicity: getting to the heart of the matter.
    Gandhi S; Verma S
    Breast Cancer Res Treat; 2007 Nov; 106(1):1-9. PubMed ID: 17211535
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Adjuvant endocrine treatment of early breast cancer.
    Lønning PE
    Hematol Oncol Clin North Am; 2007 Apr; 21(2):223-38. PubMed ID: 17512446
    [TBL] [Abstract][Full Text] [Related]  

  • 33. A practical overview of aromatase inhibitors in postmenopausal women with hormone receptor-positive breast cancer.
    Younus J; Vandenberg TA
    Bull Cancer; 2005 Apr; 92(4):E39-44. PubMed ID: 15888383
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Chemotherapy-related amenorrhea in premenopausal women with breast cancer.
    Lee S; Kil WJ; Chun M; Jung YS; Kang SY; Kang SH; Oh YT
    Menopause; 2009; 16(1):98-103. PubMed ID: 18849877
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Aromatase inhibitor-associated arthralgia syndrome.
    Burstein HJ
    Breast; 2007 Jun; 16(3):223-34. PubMed ID: 17368903
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of tamoxifen and aromatase inhibitors on the risk of fractures in women with breast cancer.
    Vestergaard P; Rejnmark L; Mosekilde L
    Calcif Tissue Int; 2008 May; 82(5):334-40. PubMed ID: 18463912
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Exemestane or tamoxifen?
    Ferretti G; Felici A; Carlini P; Cognetti F
    Lancet; 2007 May; 369(9573):1599; author reply 1600-1. PubMed ID: 17499594
    [No Abstract]   [Full Text] [Related]  

  • 38. Regression of chronic lymphocytic leukemia with aromatase inhibitor-letrozole?
    Paydas S
    Leuk Res; 2009 Apr; 33(4):566-7. PubMed ID: 18585780
    [No Abstract]   [Full Text] [Related]  

  • 39. Aromatase inhibitors in breast cancer: an overview.
    Altundag K; Ibrahim NK
    Oncologist; 2006 Jun; 11(6):553-62. PubMed ID: 16794235
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hormonal prevention of breast cancer.
    Thomin A; Friszer S; Fajac A; Daraï É; Chabbert-Buffet N
    Ann Endocrinol (Paris); 2014 Jul; 75(3):148-55. PubMed ID: 24997772
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.